About Cortalix
Cortalix is a company based in Groningen (Netherlands) founded in 2007 by Herman Steen.. Cortalix has raised $1.08 million across 1 funding round from investors including Rabobank and Future Tech Ventures. Cortalix offers products and services including Synthetic sdAb Platform, ImmunoPET Services, and CAR-T Immunotherapeutics. Cortalix operates in a competitive market with competitors including Roquette, DENAVA, MVMD, Winclove and Emergent Health Corp, among others.
- Headquarter Groningen, Netherlands
- Founders Herman Steen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cortalix Bv
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.08 M (USD)
in 1 rounds
-
Latest Funding Round
$1.08 M (USD), Seed
Mar 11, 2025
-
Investors
Rabobank
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cortalix
Cortalix offers a comprehensive portfolio of products and services, including Synthetic sdAb Platform, ImmunoPET Services, and CAR-T Immunotherapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for discovering synthetic single domain antibodies.
Services for antibody-based molecular imaging applications.
Development of antibodies for cancer immunotherapy treatments.
Funding Insights of Cortalix
Cortalix has successfully raised a total of $1.08M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.08 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.1M
-
First Round
First Round
(11 Mar 2025)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Seed - Cortalix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cortalix
Cortalix has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Rabobank and Future Tech Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in technology and impact startups.
|
Founded Year | Domain | Location | |
|
Commercial banking services are provided by Rabobank from Utrecht, Netherlands.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cortalix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cortalix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cortalix Comparisons
Competitors of Cortalix
Cortalix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roquette, DENAVA, MVMD, Winclove and Emergent Health Corp, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Plant-based pharma, nutraceuticals, and cosmetics are manufactured as a CDMO.
|
|
| domain | founded_year | HQ Location |
Investments are managed in health and digital sectors.
|
|
| domain | founded_year | HQ Location |
Biotech company focused on manufacturing neutraceuticals
|
|
| domain | founded_year | HQ Location |
Probiotic food supplements are developed and produced by Winclove.
|
|
| domain | founded_year | HQ Location |
Manufacturer of weight loss and energy supplements
|
|
| domain | founded_year | HQ Location |
Custom contract manufacturer of quality dietary supplements and homeopathic products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cortalix
When was Cortalix founded?
Cortalix was founded in 2007 and raised its 1st funding round 18 years after it was founded.
Where is Cortalix located?
Cortalix is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
Who is the current CEO of Cortalix?
Herman Steen is the current CEO of Cortalix. They have also founded this company.
Is Cortalix a funded company?
Cortalix is a funded company, having raised a total of $1.08M across 1 funding round to date. The company's 1st funding round was a Seed of $1.08M, raised on Mar 11, 2025.
What does Cortalix do?
Cortalix was founded in 2007 in Groningen, Netherlands, as a biotechnology firm focused on radiopharmaceuticals. Synthetic nanobody libraries are utilized to identify candidates for molecular imaging diagnostics and targeted radiotherapeutics, particularly for fibrogenesis-related membrane receptors and proteins. Operations include pipeline development in immunoPET and immunoRT applications. Collaborations with other organizations are maintained, and research grants have been secured to support technology advancement.
Who are the top competitors of Cortalix?
What products or services does Cortalix offer?
Cortalix offers Synthetic sdAb Platform, ImmunoPET Services, and CAR-T Immunotherapeutics.
Who are Cortalix's investors?
Cortalix has 2 investors. Key investors include Rabobank, and Future Tech Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.